• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Haemonetics Corp (NY: HAE )

    85.55 +0.12 (+0.14%)
    Official Closing Price Updated: 7:00 PM EST, Nov 22, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 480,998
    Open 85.59
    Bid (Size) 85.30 (1)
    Ask (Size) 86.04 (1)
    Prev. Close 85.43
    Today's Range 84.50 - 86.00
    52wk Range 70.25 - 97.97
    Shares Outstanding 51,029,618
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    For those who appreciate growth without the sticker shock, NYSE:HAE is worth considering.
    In the world of growth stocks, NYSE:HAE shines as a value proposition. 
    Via Chartmill
    Deep Dive Into Haemonetics Stock: Analyst Perspectives (7 Ratings)
    Via Benzinga

    Performance

    YTD
    +0.48%
    +0.48%
    1 Month
    +16.73%
    +16.73%
    3 Month
    +12.20%
    +12.20%
    6 Month
    -3.16%
    -3.16%
    1 Year
    +4.41%
    +4.41%

    More News

    Read More
    NYSE:HAE is not too expensive for the growth it is showing.
    Via Chartmill
    Despite its growth, NYSE:HAE remains within the realm of affordability.
    Via Chartmill
    Aligos Therapeutics Strengthens Senior Leadership Team with the Appointment of Hardean Achneck, MD as Chief Medical Officer
    From Aligos Therapeutics
    Via GlobeNewswire
    What Analysts Are Saying About Haemonetics Stock
    Via Benzinga
    Investors should take note of NYSE:HAE, a growth stock that remains attractively priced.
    Via Chartmill
    Analyst Expectations For Haemonetics's Future
    Via Benzinga
    NYSE:HAE stands out as a growth opportunity that won't break the bank.
    Via Chartmill
    Top 3 Health Care Stocks That Are Set To Fly This Quarter
    Via Benzinga
    Investors should take note of NYSE:HAE, a growth stock that remains attractively priced.
    Via Chartmill
    Sotera Health Appoints Christopher Simon to the Board of Directors
    From Sotera Health Services, LLC
    Via GlobeNewswire
    NYSE:HAE stands out as a growth opportunity that won't break the bank.
    Via Chartmill
    Looking for growth without the hefty price tag? Consider NYSE:HAE.
    Via Chartmill
    NYSE:HAE, a growth stock which is not overvalued.
    Via Chartmill
    4 Analysts Assess Haemonetics: What You Need To Know
    Via Benzinga
    Earnings Scheduled For February 8, 2024
    Via Benzinga
    Haemonetics' Strategic Moves Poised To Boost Margins And Earnings, Says Analyst
    Via Benzinga
    This McCormick Analyst Is No Longer Bearish; Here Are Top 5 Upgrades For Wednesday
    Via Benzinga
    These 3 Companies Boast Bright Outlooks
    Via Talk Markets
    12 Health Care Stocks Moving In Tuesday's After-Market Session
    Via Benzinga
    HAE Stock Earnings: Haemonetics Beats EPS, Beats Revenue for Q4 2024
    Via InvestorPlace
    For those who appreciate growth without the sticker shock, NYSE:HAE is worth considering.
    Via Chartmill
    Intuitive Surgical Stock Earns Relative Strength Rating Upgrade; Hits Key Benchmark
    Via Investor's Business Daily
    Intuitive Surgical Stock Rating Climbs As Sales, Profits Rise
    Via Investor's Business Daily
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.